Literature DB >> 9835260

ST segment elevation induced by class IC antiarrhythmic agents: underlying electrophysiologic mechanisms and insights into drug-induced proarrhythmia.

S C Krishnan1, M E Josephson.   

Abstract

Three patients in whom Class IC sodium channel blockers induced ST segment elevation in leads V1 through V3 are described. The underlying electrophysiologic mechanism, implications for drug-induced proarrhythmia, and the relationship of the finding to the Brugada syndrome type of idiopathic ventricular fibrillation are discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9835260     DOI: 10.1111/j.1540-8167.1998.tb00088.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  12 in total

Review 1.  Drug-induced spatial dispersion of repolarization.

Authors:  Charles Antzelevitch
Journal:  Cardiol J       Date:  2008       Impact factor: 2.737

Review 2.  Brugada syndrome.

Authors:  Charles Antzelevitch
Journal:  Pacing Clin Electrophysiol       Date:  2006-10       Impact factor: 1.976

Review 3.  The Brugada syndrome.

Authors:  P Brugada; R Brugada; J Brugada
Journal:  Curr Cardiol Rep       Date:  2000-11       Impact factor: 2.931

Review 4.  Brugada syndrome: from cell to bedside.

Authors:  Charles Antzelevitch; Pedro Brugada; Josep Brugada; Ramon Brugada
Journal:  Curr Probl Cardiol       Date:  2005-01       Impact factor: 5.200

Review 5.  Therapy for the Brugada syndrome.

Authors:  C Antzelevitch; J M Fish
Journal:  Handb Exp Pharmacol       Date:  2006

Review 6.  Brugada syndrome: current clinical aspects and risk stratification.

Authors:  Takanori Ikeda
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-07       Impact factor: 1.468

Review 7.  Ventricular tachycardia in structurally normal hearts.

Authors:  T Scott Wall; Roger A Freedman
Journal:  Curr Cardiol Rep       Date:  2002-09       Impact factor: 2.931

Review 8.  Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org).

Authors:  Pieter G Postema; Christian Wolpert; Ahmad S Amin; Vincent Probst; Martin Borggrefe; Dan M Roden; Silvia G Priori; Hanno L Tan; Masayasu Hiraoka; Josep Brugada; Arthur A M Wilde
Journal:  Heart Rhythm       Date:  2009-07-08       Impact factor: 6.343

Review 9.  Brugada Syndrome: Clinical, Genetic, Molecular, Cellular, and Ionic Aspects.

Authors:  Charles Antzelevitch; Bence Patocskai
Journal:  Curr Probl Cardiol       Date:  2015-06-11       Impact factor: 5.200

10.  Abnormal response to sodium channel blockers in patients with Brugada syndrome: augmented localised wall motion abnormalities in the right ventricular outflow tract region detected by electron beam computed tomography.

Authors:  M Takagi; N Aihara; S Kuribayashi; A Taguchi; T Kurita; K Suyama; S Kamakura; M Takamiya
Journal:  Heart       Date:  2003-02       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.